Adicet Bio, Inc. Increase (Decrease) in Accounts Payable
Adicet Bio, Inc. (ACET) reported Increase (Decrease) in Accounts Payable of -$1.14 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-08-05
- Adicet Bio, Inc. increase (decrease) in accounts payable for the quarter ending 2026-06-30 was $664.00K.
- Adicet Bio, Inc. increase (decrease) in accounts payable for the quarter ending 2026-03-31 was -$1.80M, a 386.17% decline year-over-year.
- Adicet Bio, Inc. increase (decrease) in accounts payable for the quarter ending 2025-12-31 was $307.00K, a 73.37% decline year-over-year.
- Adicet Bio, Inc. increase (decrease) in accounts payable for the quarter ending 2025-09-30 was $1.21M, a 66.62% increase year-over-year.
- Adicet Bio, Inc. increase (decrease) in accounts payable for fiscal 2025 was $1.03M, a 6.96% decline from fiscal 2024.
- Adicet Bio, Inc. increase (decrease) in accounts payable for fiscal 2024 was $1.11M.
- Adicet Bio, Inc. increase (decrease) in accounts payable for fiscal 2023 was -$1.68M, a 198.42% decline from fiscal 2022.
- Adicet Bio, Inc. increase (decrease) in accounts payable for fiscal 2022 was $1.71M, a 50.40% increase from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 3 month as first filed | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 6 month as first filed | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 9 month as first filed | Increase (Decrease) in Accounts Payable 12 month | Increase (Decrease) in Accounts Payable 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $664.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$1.14M 10-Q · filed 2026-08-05 | -$829.00K derived: sum of 3 quarters · filed 2026-08-05 | $384.00K derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2026-03-31 | -$1.80M 10-Q · filed 2026-05-13 | -$1.49M derived: sum of 2 quarters · filed 2026-05-13 | -$280.00K derived: sum of 3 quarters · filed 2026-05-13 | -$1.40M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-12-31 | $307.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $1.52M derived: sum of 2 quarters · filed 2026-03-12 | $400.00K derived: sum of 3 quarters · filed 2026-08-05 | $1.03M 10-K · filed 2026-03-12 | ||||
| 2025-09-30 | $1.21M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $93.00K derived: sum of 2 quarters · filed 2026-08-05 | $722.00K 10-Q · filed 2025-11-05 | $1.88M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-06-30 | -$1.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$491.00K 10-Q · filed 2026-08-05 | $662.00K derived: sum of 3 quarters · filed 2026-08-05 | $1.39M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-03-31 | $629.00K 10-Q · filed 2026-05-13 | $1.78M derived: sum of 2 quarters · filed 2026-05-13 | $2.51M derived: sum of 3 quarters · filed 2026-05-13 | $1.94M derived: sum of 4 quarters · filed 2026-05-13 | ||||
| 2024-12-31 | $1.15M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $1.88M derived: sum of 2 quarters · filed 2026-03-12 | $1.31M derived: sum of 3 quarters · filed 2026-03-12 | $1.11M 10-K · filed 2026-03-12 | ||||
| 2024-09-30 | $728.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $161.00K derived: sum of 2 quarters · filed 2025-11-05 | -$47.00K 10-Q · filed 2025-11-05 | -$1.51M derived: sum of 4 quarters · filed 2025-11-05 | ||||
| 2024-06-30 | -$567.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$775.00K 10-Q · filed 2025-08-07 | -$2.23M derived: sum of 3 quarters · filed 2025-08-07 | -$834.00K derived: sum of 4 quarters · filed 2025-08-07 | ||||
| 2024-03-31 | -$208.00K 10-Q · filed 2025-05-06 | -$1.67M derived: sum of 2 quarters · filed 2025-05-06 | -$267.00K derived: sum of 3 quarters · filed 2025-05-06 | $442.00K derived: sum of 4 quarters · filed 2025-05-06 | ||||
| 2023-12-31 | -$1.46M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | -$59.00K derived: sum of 2 quarters · filed 2025-03-06 | $650.00K derived: sum of 3 quarters · filed 2025-03-06 | -$1.68M 10-K · filed 2025-03-06 | ||||
| 2023-09-30 | $1.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $2.11M derived: sum of 2 quarters · filed 2024-11-06 | -$223.00K 10-Q · filed 2024-11-06 | $931.00K derived: sum of 4 quarters · filed 2024-11-06 | ||||
| 2023-06-30 | $709.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | -$1.62M 10-Q · filed 2024-08-13 | -$470.00K derived: sum of 3 quarters · filed 2024-08-13 | $1.27M derived: sum of 4 quarters · filed 2024-08-13 | ||||
| 2023-03-31 | -$2.33M 10-Q · filed 2024-05-14 | -$1.18M derived: sum of 2 quarters · filed 2024-05-14 | $563.00K derived: sum of 3 quarters · filed 2024-05-14 | -$11.00K derived: sum of 4 quarters · filed 2024-05-14 | ||||
| 2022-12-31 | $1.15M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19 | $2.90M derived: sum of 2 quarters · filed 2024-03-19 | $2.32M derived: sum of 3 quarters · filed 2024-03-19 | $1.71M 10-K · filed 2024-03-19 | ||||
| 2022-09-30 | $1.74M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $1.17M derived: sum of 2 quarters · filed 2023-11-08 | $556.00K 10-Q · filed 2023-11-08 | -$1.39M derived: sum of 4 quarters · filed 2023-11-08 | ||||
| 2022-06-30 | -$574.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$1.19M 10-Q · filed 2023-08-09 | -$3.13M derived: sum of 3 quarters · filed 2023-08-09 | -$813.00K derived: sum of 4 quarters · filed 2023-08-09 | ||||
| 2022-03-31 | -$612.00K 10-Q · filed 2023-05-09 | -$2.55M derived: sum of 2 quarters · filed 2023-05-09 | -$239.00K derived: sum of 3 quarters · filed 2023-05-09 | $329.00K derived: sum of 4 quarters · filed 2023-05-09 | ||||
| 2021-12-31 | -$1.94M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | $373.00K derived: sum of 2 quarters · filed 2023-03-15 | $941.00K derived: sum of 3 quarters · filed 2023-03-15 | $1.14M 10-K · filed 2023-03-15 | ||||
| 2021-09-30 | $2.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $2.88M derived: sum of 2 quarters · filed 2022-11-08 | $3.08M 10-Q · filed 2022-11-08 | $823.00K derived: sum of 4 quarters · filed 2022-11-08 | ||||
| 2021-06-30 | $568.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | $764.00K 10-Q · filed 2022-08-10 | -$1.49M derived: sum of 3 quarters · filed 2022-08-10 | -$1.16M derived: sum of 4 quarters · filed 2022-08-10 | ||||
| 2021-03-31 | $196.00K 10-Q · filed 2022-05-12 | -$2.06M derived: sum of 2 quarters · filed 2022-05-12 | -$1.73M derived: sum of 3 quarters · filed 2022-05-12 | -$934.00K derived: sum of 4 quarters · filed 2022-05-12 | ||||
| 2020-12-31 | -$2.26M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | -$1.93M derived: sum of 2 quarters · filed 2022-03-15 | -$1.13M derived: sum of 3 quarters · filed 2022-03-15 | -$814.00K 10-K · filed 2022-03-15 | ||||
| 2020-09-30 | $328.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $1.13M derived: sum of 2 quarters · filed 2021-11-10 | $1.44M 10-Q · filed 2021-11-10 | $1.73M derived: sum of 4 quarters · filed 2021-11-10 | ||||
| 2020-06-30 | $798.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $1.11M 10-Q · filed 2021-08-12 | -$4.25M 10-Q · filed 2020-07-30 | $1.40M derived: sum of 3 quarters · filed 2021-08-12 | -$3.56M derived: sum of 4 quarters · filed 2021-08-12 | |||
| 2020-03-31 | $316.00K 10-Q · filed 2021-05-17 | -$5.51M 10-Q · filed 2020-05-07 | $599.00K derived: sum of 2 quarters · filed 2021-05-17 | -$4.35M derived: sum of 3 quarters · filed 2021-05-17 | $699.00K derived: sum of 4 quarters · filed 2021-05-17 | |||
| 2019-12-31 | $283.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | -$4.67M derived: sum of 2 quarters · filed 2021-03-12 | $383.00K derived: sum of 3 quarters · filed 2021-03-12 | $527.00K 10-K · filed 2021-03-12 | $3.73M 10-K · filed 2020-03-12 | |||
| 2019-09-30 | -$4.95M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $100.00K derived: sum of 2 quarters · filed 2020-11-05 | $244.00K 10-Q · filed 2020-11-05 | $6.97M 10-Q · filed 2019-11-05 | -$2.85M derived: sum of 4 quarters · filed 2021-03-12 | |||
| 2019-06-30 | $5.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-30 | $5.20M 10-Q · filed 2020-07-30 | $2.11M derived: sum of 3 quarters · filed 2021-03-12 | $1.80M derived: sum of 4 quarters · filed 2021-03-12 | ||||
| 2019-03-31 | $144.00K 10-Q · filed 2020-05-07 | -$2.94M derived: sum of 2 quarters · filed 2021-03-12 | -$3.26M derived: sum of 3 quarters · filed 2021-03-12 | -$218.00K derived: sum of 4 quarters · filed 2021-03-12 | ||||
| 2018-12-31 | -$3.09M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | -$3.40M derived: sum of 2 quarters · filed 2021-03-12 | -$362.00K derived: sum of 3 quarters · filed 2021-03-12 | -$282.00K 10-K · filed 2021-03-12 | $1.60M 10-K · filed 2019-03-18 | |||
| 2018-09-30 | -$312.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $2.73M derived: sum of 2 quarters · filed 2019-11-05 | $2.81M 10-Q · filed 2019-11-05 | $3.10M derived: sum of 4 quarters · filed 2020-03-12 | ||||
| 2018-06-30 | $3.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $3.12M 10-Q · filed 2019-08-14 | $3.42M derived: sum of 3 quarters · filed 2020-03-12 | $2.26M derived: sum of 4 quarters · filed 2020-03-12 | ||||
| 2018-03-31 | $80.00K 10-Q · filed 2019-05-15 | $378.00K derived: sum of 2 quarters · filed 2020-03-12 | -$775.00K derived: sum of 3 quarters · filed 2020-03-12 | $1.46M derived: sum of 4 quarters · filed 2020-03-12 | ||||
| 2017-12-31 | $298.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | -$855.00K derived: sum of 2 quarters · filed 2020-03-12 | $1.38M derived: sum of 3 quarters · filed 2020-03-12 | $1.39M 10-K · filed 2020-03-12 | ||||
| 2017-09-30 | -$1.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | $1.08M derived: sum of 2 quarters · filed 2018-11-13 | $1.09M 10-Q · filed 2018-11-13 | |||||
| 2017-06-30 | $2.24M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $2.25M 10-Q · filed 2018-08-09 | ||||||
| 2017-03-31 | $10.00K 10-Q · filed 2018-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |